Arca
Skip to content
Tools
Tools

-pril

An ACE inhibitor: blocks the enzyme that makes angiotensin II, lowering blood pressure.

  • Drugs ending in -pril: 17
  • Approved somewhere: 13
  • With a US drug page: 9

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-pril
Class
ACE inhibitors, which lower blood pressure
Sub-stems
-prilat
Most common targets
ACE (15)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -pril or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
BenazeprilApprovedACEAngiotensin-converting enzyme inhibitor
CaptoprilApprovedACEAngiotensin-converting enzyme inhibitor
EnalaprilApprovedACEAngiotensin-converting enzyme inhibitor
FosinoprilApprovedACEAngiotensin-converting enzyme inhibitor
MoexiprilApprovedACEAngiotensin-converting enzyme inhibitor
QuinaprilApprovedACEAngiotensin-converting enzyme inhibitor
RamiprilApprovedACEAngiotensin-converting enzyme inhibitor
SpiraprilApprovedACEAngiotensin-converting enzyme inhibitor
TrandolaprilApprovedACEAngiotensin-converting enzyme inhibitor
CilazaprilApprovedACEAngiotensin-converting enzyme inhibitor
ImidaprilApprovedACEAngiotensin-converting enzyme inhibitor
Lisinopril anhydrousApprovedACEAngiotensin-converting enzyme inhibitor
PerindoprilApprovedACEAngiotensin-converting enzyme inhibitor
DelaprilPhase 3ACEAngiotensin-converting enzyme inhibitor
TemocaprilPhase 2——
ZofenoprilPhase 2——
Enalaprilat anhydrousPhase 3ACEAngiotensin-converting enzyme inhibitor

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.